PortfoliosLab logoPortfoliosLab logo
TMED vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

TMED vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in T. Rowe Price Health Care ETF (TMED) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


TMED

1D
1.04%
1M
2.47%
YTD
3.87%
6M
4.17%
1Y
3Y*
5Y*
10Y*

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

TMED vs. GERM - Yearly Performance Comparison


Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

TMED vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for T. Rowe Price Health Care ETF (TMED) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

TMED vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


TMEDGERMDifference

Sharpe Ratio (All Time)

Calculated using the full available price history

1.35

Drawdowns

TMED vs. GERM - Drawdown Comparison

The maximum TMED drawdown since its inception was -11.11%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for TMED and GERM.


Loading charts...

Drawdown Indicators


TMEDGERMDifference

Max Drawdown

Largest peak-to-trough decline

-11.11%

0.00%

-11.11%

Max Drawdown (1Y)

Largest decline over 1 year

0.00%

Current Drawdown

Current decline from peak

-2.75%

0.00%

-2.75%

Average Drawdown

Average peak-to-trough decline

-2.59%

0.00%

-2.59%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.00%

Volatility

TMED vs. GERM - Volatility Comparison


Loading charts...

Volatility by Period


TMEDGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.00%

Volatility (6M)

Calculated over the trailing 6-month period

0.00%

Volatility (1Y)

Calculated over the trailing 1-year period

18.04%

0.00%

+18.04%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.04%

0.00%

+18.04%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.04%

0.00%

+18.04%

TMED vs. GERM - Expense Ratio Comparison

TMED has a 0.44% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

TMED vs. GERM - Dividend Comparison

TMED's dividend yield for the trailing twelve months is around 0.52%, while GERM has not paid dividends to shareholders.


Frequently Asked Questions


On fees, TMED is cheaper at 0.44% per year. The better choice depends on whether you care most about return, fees, risk, or income.

TMED is cheaper with a 0.44% expense ratio, compared with 0.68% for GERM.

TMED has the higher dividend yield at 0.52%, compared with 0.00% for GERM.

They also come from different issuers: T. Rowe Price and Amplify. Their fees differ too: 0.44% for TMED and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for TMED and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer